Literature DB >> 19250275

Intrinsic defect of the immune system in children with Down syndrome: a review.

M A A Kusters1, R H J Verstegen, E F A Gemen, E de Vries.   

Abstract

Down syndrome (DS) is the most frequent cause of mental retardation in man. Immunological changes in DS have been observed since the 1970s. The neurological system appears to be ageing precociously, with early occurrence of Alzheimer disease; until now, the observed immunological differences have been interpreted in the same context. Looking back at past and present results of immunological studies in DS children in relation to the clinical consequences they suffer, we conclude that it is more likely that the DS immune system is intrinsically deficient from the very beginning.

Entities:  

Mesh:

Year:  2009        PMID: 19250275      PMCID: PMC2759463          DOI: 10.1111/j.1365-2249.2009.03890.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  71 in total

1.  Down syndrome (trisomy 21) thymuses have a decreased proportion of cells expressing high levels of TCR alpha, beta and CD3. A possible mechanism for diminished T cell function in Down syndrome.

Authors:  M Murphy; L B Epstein
Journal:  Clin Immunol Immunopathol       Date:  1990-06

2.  Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers.

Authors:  A Cossarizza; D Monti; G Montagnani; C Ortolani; M Masi; M Zannotti; C Franceschi
Journal:  Am J Med Genet Suppl       Date:  1990

3.  Intrathymic deficient expansion of T cell precursors in Down syndrome.

Authors:  P Musiani; S Valitutti; F Castellino; L M Larocca; N Maggiano; M Piantelli
Journal:  Am J Med Genet Suppl       Date:  1990

4.  [Response to recombinant DNA antihepatitis B vaccine in mentally retarded patients with Down's syndrome. A controlled study].

Authors:  M García Bengoechea; A Cortés; J Cabriada; I Albizu; M Dorronsoro; J A Arriola; J I Arenas
Journal:  Med Clin (Barc)       Date:  1990-04-14       Impact factor: 1.725

Review 5.  Immunology of Down syndrome: a review.

Authors:  A G Ugazio; R Maccario; L D Notarangelo; G R Burgio
Journal:  Am J Med Genet Suppl       Date:  1990

Review 6.  Abnormalities of the immune response to influenza antigen in Down syndrome (trisomy 21).

Authors:  L B Epstein; R Philip
Journal:  Prog Clin Biol Res       Date:  1987

7.  Age-related changes in humoral and cell-mediated immunity in Down syndrome children living at home.

Authors:  G Lockitch; V K Singh; M L Puterman; W J Godolphin; S Sheps; A J Tingle; F Wong; G Quigley
Journal:  Pediatr Res       Date:  1987-11       Impact factor: 3.756

8.  Prevalence and diagnostic significance of gliadin antibodies in children with Down syndrome.

Authors:  W Storm
Journal:  Eur J Pediatr       Date:  1990-09       Impact factor: 3.183

9.  Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21).

Authors:  R Philip; A C Berger; N H McManus; N H Warner; M A Peacock; L B Epstein
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

10.  Normal immune response to hepatitis B vaccine in patients with Down's syndrome. A basis for immunization guidelines.

Authors:  C L Troisi; D A Heiberg; F B Hollinger
Journal:  JAMA       Date:  1985-12-13       Impact factor: 56.272

View more
  71 in total

1.  The effect of conventional mechanical periodontal treatment on red complex microorganisms and clinical parameters in Down syndrome periodontitis patients: a pilot study.

Authors:  M H Tanaka; T O Rodrigues; L S Finoti; S R L Teixeira; M P A Mayer; R M Scarel-Caminaga; E M A Giro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-04       Impact factor: 3.267

2.  Phagocytic cell activity and periodontitis in Down syndrome.

Authors:  A Khocht; B Russell; J G Cannon; B Turner; M Janal
Journal:  Oral Dis       Date:  2011-11-29       Impact factor: 3.511

3.  Down syndrome: is it really characterized by precocious immunosenescence?

Authors:  Maaike Aa Kusters; Ruud Hj Verstegen; Esther de Vries
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

4.  Pupil and salivary indicators of autonomic dysfunction in autism spectrum disorder.

Authors:  Christa J Anderson; John Colombo; Kathryn E Unruh
Journal:  Dev Psychobiol       Date:  2012-05-29       Impact factor: 3.038

Review 5.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

6.  Trisomy 21 Is a Cause of Permanent Neonatal Diabetes That Is Autoimmune but Not HLA Associated.

Authors:  Matthew B Johnson; Elisa De Franco; Siri Atma W Greeley; Lisa R Letourneau; Kathleen M Gillespie; Matthew N Wakeling; Sian Ellard; Sarah E Flanagan; Kashyap A Patel; Andrew T Hattersley
Journal:  Diabetes       Date:  2019-04-08       Impact factor: 9.461

7.  Age-related alterations of the CD19 complex and memory B cells in children with Down syndrome.

Authors:  Ayse Nazli Seckin; Hulya Ozdemir; Ayca Ceylan; Hasibe Artac
Journal:  Clin Exp Med       Date:  2017-02-14       Impact factor: 3.984

8.  T-helper-related cytokines in gingival crevicular fluid from adolescents with Down syndrome.

Authors:  Georgios Tsilingaridis; Tülay Yucel-Lindberg; Thomas Modéer
Journal:  Clin Oral Investig       Date:  2011-01-08       Impact factor: 3.573

9.  Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.

Authors:  Laureanne P E Lorenzo; Kristen E Shatynski; Sarah Clark; Paul J Yarowsky; Mark S Williams
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

10.  Telomere shortening in Down syndrome patients--when does it start?

Authors:  Aleksandra Gruszecka; Przemysław Kopczyński; Dorota Cudziło; Natalia Lipińska; Aleksandra Romaniuk; Wojciech Barczak; Natalia Rozwadowska; Ewa Totoń; Błażej Rubiś
Journal:  DNA Cell Biol       Date:  2015-03-18       Impact factor: 3.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.